|
Propoxyphene Compound 65Drug - Propoxyphene Compound 65 The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Aspirin; Caffeine; Propoxyphene Hydrochloride
Strength -
389MG;32.4MG;65MG
Applicant -
TEVA
New Drug Application (NDA) Number -
089025
Product Number -
001
Therapeutic Equivalence (TE) Code -
AA
Approval Date -
Mar 29, 1985
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Teva Pharmaceuticals Usa Inc
Propoxyphene Compound 65
Darvon Compound 389mg;32.4mg;32mg Capsule; Oral
Darvon Compound-65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Propoxyphene Compound 65 389mg;32.4mg;65mg Capsule; Oral Orphenadrine Citrate, Aspirin, And Caffeine 385mg;30mg;25mg Tablet; Oral Orphenadrine Citrate, Aspirin, And Caffeine 770mg;60mg;50mg Tablet; Oral Orphengesic 385mg;30mg;25mg Tablet; Oral Orphengesic Forte 770mg;60mg;50mg Tablet; Oral Compound 65 389mg;32.4mg;65mg Capsule; Oral NewDrugInformation |